# Pass 2 Rebuttals — DCF Analyst
**Date:** 2026-03-09
**Subject:** Advanced Micro Devices, Inc. (AMD)

---

## Response to Quant Analyst's Critique

### Weakest Assumption: WACC of 16.0% (Beta 2.02, ERP 5.50%)
**Verdict: Partially Accept**

The Quant Analyst makes the strongest version of the WACC critique: at the market-implied WACC of 12.5-13.5%, the base case DCF aligns with the comps-derived $207 estimate, and the 250-350bps gap between my 16% and the market-implied rate is what drives the overvaluation call. I accept that a static 2.02 beta likely overstates AMD's forward systematic risk as the revenue mix shifts toward contracted mega-deal volumes with multi-year visibility. The argument that contracted revenue from OpenAI and Meta reduces revenue uncertainty (and therefore should compress beta) has merit — though I note that contract realization itself is uncertain, so the revenue is "committed" but not "guaranteed." I will revise the model to present a dual-WACC framework: (1) the observed 16% WACC as the conservative case, and (2) a forward-looking 13.5-14% WACC reflecting beta compression to ~1.6 as the central case. At 14% WACC, the base case fair value rises to approximately $195-205, shifting the conclusion from "overvalued" to "approximately fairly valued." The sensitivity table already captures this range, but I accept the critique that the point estimate should not anchor solely on the backward-looking beta. The core disagreement — whether the market's implied WACC or the observed beta is more informative — is a genuine analytical judgment call that the Director should resolve.

### Most Likely Source of Error: ERP Estimated Without Primary Source
**Verdict: Accept**

The Quant Analyst correctly notes that the 5.50% ERP is tagged [ESTIMATED] without a primary source, and the Research Analyst's critique reinforces this — for a variable this consequential, estimated is not acceptable. Damodaran's January 2025 published ERP was 4.60%; my 90bps upward adjustment to 5.50% for the elevated rate environment in early 2026 was a judgment call, not a sourced figure. At 4.75% ERP (Damodaran's typical implied ERP in normal markets), WACC drops to ~14.8% and the base case rises to $175-185. I will flag the ERP as a [DATA GAP: Damodaran January 2026 ERP not retrieved] and present the sensitivity range at 4.75%, 5.25%, and 5.50% ERP, rather than anchoring on a single unsourced estimate. This correction, combined with the beta discussion above, widens the fair value range but makes it more honest.

### Recommended Change: Forward-Looking Beta Rather Than Trailing
**Verdict: Partially Accept**

I accept the directional argument that a 5-year trailing beta of 2.02 captures AMD's pre-AI-pivot volatility (including the 2022 crypto crash and 2024 tariff shock) and likely overstates forward risk. However, I reject the suggestion that mega-deal contracted revenue alone justifies a beta of 1.5-1.7. The mega-deals are for a product (MI450) that has not shipped, through a software stack (ROCm) that trails the competitor by a wide margin, with customers who are simultaneously developing substitutes (OpenAI-Broadcom, Meta internal silicon). "Contracted" revenue from an unshipped product is not the same as recurring SaaS revenue. I will present a blended approach: trailing beta of 2.02 for the near-term (FY2026-2027) when execution risk is highest, declining to 1.6 for FY2028-2030 as the product cycle matures, yielding a blended WACC of approximately 14.5-15%. This is a meaningful concession that moves the base case from $155 to approximately $175-185.

---

## Response to Devil's Advocate's Critique

### Weakest Assumption: Mega-Deal Realization Rate of 75% Base Case
**Verdict: Partially Accept**

The Devil's Advocate makes a compelling case that 75% realization has no empirical foundation in AMD's history and cites relevant precedents (TSMC-Intel at 40-50%, Qualcomm Centriq at <20%, Intel Habana at <30%). I accept that these precedents are informative and that AMD has never executed at this scale for AI GPUs. However, the cited comparables are structurally different: TSMC-Intel involved Intel attempting to outsource to a competitor's manufacturing process; Qualcomm Centriq and Intel Habana were products that failed technically. The AMD mega-deals are for GPUs that build on MI350 architecture already deployed at 8 of 10 top AI companies, with customer-specific variants (Meta's custom MI450) indicating deep co-engineering. I will revise the base case realization to 65% (down from 75%) and adjust the bear case to 35% (down from 40%), reflecting the ASIC substitution risk the Devil's Advocate correctly identifies. This reduces the base case fair value by approximately $15-20/share (from $155 to ~$135-140 at the original 16% WACC, or ~$165-175 at the revised 14.5% WACC). The 65% figure splits the difference between the DA's implied 50-60% and my original 75%, anchored on the specific structural features of these deals (warrant-linked milestones, co-engineering) that differentiate them from the cited precedents.

### Most Likely Source of Error: Terminal Value Dominance (72-80% of EV)
**Verdict: Accept with Qualification**

The DA and Forensic Analyst both correctly flag that when TV is 72-80% of EV, the DCF is effectively a disguised multiples model. I accept this characterization — the 5-year forecast captures the build phase, not the harvest phase, and the valuation depends overwhelmingly on terminal assumptions. However, I reject the implication that this invalidates the DCF. TV dominance of 70-80% is structural for any company growing at 23%+ CAGR with heavy reinvestment; NVIDIA's DCF has similar characteristics. The appropriate response is not to abandon the DCF but to weight the sensitivity tables more heavily than the point estimate. I already flagged this in Section 9 of the report. I will add a header note directing the reader to treat the sensitivity table as the primary output and the point estimate as illustrative.

### Recommended Change: Lower Bear Case Price Floor
**Verdict: Reject**

The DA suggests the bear case should be lower than $84 given the cited precedents. The Forensic Analyst and Catalyst Analyst both argue the opposite — that $84 is too low because AMD generates $6.7B FCF, holds $10.6B cash, and has a $9.4B buyback authorization that would accelerate at lower prices. At $84, AMD trades at approximately 12x trailing earnings with a 5.2% FCF yield — a level that would make it a deep-value stock attracting fundamental buyers. The Altman Z-Score of 14.38 rules out financial distress. I maintain $84 as the bear case because it represents a scenario where the AI GPU thesis fails entirely and the market assigns a distressed-cyclical multiple to the remaining EPYC + embedded business. I note, however, that the Catalyst Analyst's point about the buyback floor is valid and may provide a practical floor of $100-110.

---

## Response to Risk Analyst's Critique

### Weakest Assumption: Static WACC Through 2030
**Verdict: Partially Accept**

The Risk Analyst's argument that AMD's beta should compress as it scales from $35B to $98B revenue, with the precedent that Intel's beta was 0.8-1.2 at peak, is well-taken. The suggestion to model WACC as declining from 16% to 13% over the projection period is directionally correct — if AMD executes on the mega-deals, its business profile does become more predictable. However, Intel's low beta reflected a monopoly position with 90%+ server CPU share; AMD at 45-50% share in a duopoly with Intel plus ARM entry does not have the same structural predictability. I will adopt a step-down WACC (16% in FY2026, 15% in FY2027-2028, 14% in FY2029-2030) rather than a flat 16%, which shifts the base case from $155 to approximately $180-190. This is a significant revision that narrows the gap with the current stock price.

### Most Likely Source of Error: Terminal Value as 72-80% of EV
**Verdict: Accept**

Same response as to the DA above — I accept that TV dominance is structural and that the sensitivity table should be treated as the primary output. I will present three TV blend scenarios (40/60, 50/50, 60/40 between perpetuity growth and exit multiple) as the Research Analyst suggests, which adds $15-30/share of range to the fair value estimate and eliminates the arbitrary anchoring on a single blend.

---

## Response to Macro Analyst's Critique

### Weakest Assumption: No Cyclical Correction in Base Case Revenue
**Verdict: Partially Accept**

The Macro Analyst's argument is sharp: every prior semiconductor capex super-cycle experienced at least one 30-50% correction within a 5-year window, and a base case that embeds no cyclical correction is not a base case. I accept the principle — historical base rates for semiconductor cyclicality should inform the forecast. However, the AI capex cycle differs from prior cycles in that the spending is driven by 4-5 hyperscalers with $300B+ combined annual FCF, not by levered telecom operators or speculative crypto miners. The spending is strategic competitive investment, not discretionary capacity build. I will add a mid-cycle correction scenario overlay: a 15-20% revenue growth deceleration in FY2028 (from 24.6% to ~10-12%) followed by recovery in FY2029, which reduces FY2030 revenue from $98.5B to approximately $88-92B. This reduces the base case fair value by approximately $10-15/share. I do not accept the 30-50% correction magnitude as appropriate for the base case because the contracted mega-deal structure provides a revenue floor that prior semiconductor cycles lacked.

### Most Likely Source of Error: Static Beta in WACC
**Verdict: Accept**

Addressed above in the Risk Analyst rebuttal. I will implement a declining WACC schedule.

### Recommended Change: Reconcile DCF Terminal Growth with Semiconductor Cyclicality
**Verdict: Accept**

The Macro Analyst correctly notes that a 3.0% terminal growth rate is aggressive for a semiconductor company at terminal maturity given historical cyclicality. I will reduce the base case terminal growth rate from 3.0% to 2.5%, which reduces the perpetuity growth TV and shifts the base case fair value down by approximately $5-8/share at the 60/40 TV blend. At the revised step-down WACC of ~14.5% average, this moves the base case from ~$185 to ~$178-180.

---

## Response to Competitive Analyst's Critique

### Weakest Assumption: Mega-Deal Realization Should Be 50-60% (Bridge Contracts)
**Verdict: Partially Accept**

The Competitive Analyst argues that OpenAI and Meta mega-deals are "bridge contracts" because both customers are simultaneously developing custom ASICs, and a competitively-informed realization should be 50-60%. This overlaps with the Devil's Advocate's critique. I accept that ASIC substitution is a real risk that reduces mega-deal realization below 75%. However, 50-60% understates the stickiness of GPU infrastructure for two reasons: (1) the Catalyst Analyst correctly notes that custom ASICs take 3-5 years from design to production, so AMD GPUs arrive first and create an installed base with switching costs; (2) the Sector Analyst's observation that ASICs and GPUs serve different workload layers (ASICs for narrow inference, GPUs for training and flexible compute) means they coexist rather than substitute. I have already revised to 65% base case realization per the DA critique. I reject going lower than 65% because the warrant structure — which vests on deployment milestones — creates real customer incentives to deploy AMD hardware at scale, not just sign contracts.

### Most Likely Source of Error: WACC Static
**Verdict: Accept**

Addressed in prior rebuttals. Declining WACC adopted.

---

## Response to Credit Analyst's Critique

### Weakest Assumption: WACC Inconsistent with AMD's Credit Quality
**Verdict: Partially Accept**

The Credit Analyst makes a distinct version of the WACC critique grounded in balance sheet fundamentals: AMD has $7.25B net cash, 100% fixed-rate debt, interest coverage >50x, and A/A1 credit ratings — a profile comparable to Qualcomm (beta 1.2-1.4). The argument that AMD's backward-looking beta reflects its speculative turnaround era rather than its current investment-grade credit profile is persuasive. I accept that the credit profile supports a lower beta than 2.02. However, AMD's equity risk is driven by revenue concentration in AI GPUs (a hyper-cyclical, unproven market at scale) and customer concentration (two mega-deal customers representing ~35% of FY2028E revenue), not by balance sheet risk. A strong balance sheet does not immunize equity holders from a 50% revenue growth miss. The step-down WACC I have adopted (16% declining to 14%) partially addresses this critique. I do not accept the Credit Analyst's implied WACC of 13-13.5% because it underweights the execution and cyclicality risks that are distinct from credit risk.

### Most Likely Source of Error: No Governance Risk Premium
**Verdict: Reject**

The ESG Analyst suggests adding 10-15bps for governance risk (combined Chair/CEO, warrants without shareholder vote). While these are legitimate governance concerns, I reject embedding them in WACC for two reasons: (1) the magnitude is immaterial — 15bps on a 14-16% WACC changes fair value by ~$1-2/share, which is noise; (2) governance risk is better captured as a discrete scenario (additional warrant issuances reducing per-share value) rather than a continuous discount rate adjustment. The ESG Analyst's own suggested approach — modeling warrant dilution probabilistically — is superior to a WACC adjustment and is already implemented in my scenario-specific share count methodology.

---

## Response to Forensic Analyst's Critique

### Weakest Assumption: Terminal Gross Margin of 57.5% Overstated
**Verdict: Partially Accept**

The Forensic Analyst correctly identifies that Q4 2025's 57% gross margin was inflated by the $306M inventory reserve release, making the underlying margin ~54%. I accept that the starting point for the margin trajectory should be 54-55%, not 57%. However, the terminal gross margin of 57.5% by FY2030 is a 5-year forward projection driven by mix shift toward Data Center (74% of revenue by FY2030 at estimated 60-65% segment gross margin). Management guided Q1 2026 at 55%, which is between the forensic "underlying 54%" and the headline 57%, suggesting the true run rate is normalizing toward 55% — consistent with mix improvement. I will revise the FY2026 starting gross margin from 54% to 53.5% (acknowledging the forensic finding) while maintaining the terminal 57.5%, resulting in a slightly steeper margin expansion curve. Net impact on the base case: approximately -$3-5/share, which I accept.

### Most Likely Source of Error: TV Blend Methodology Unjustified
**Verdict: Partially Accept**

The Forensic Analyst and Research Analyst both critique the 60/40 blend of exit multiple vs. perpetuity growth as arbitrary. I accept this and will present three blend scenarios as noted in the Risk Analyst rebuttal. I partially reject the characterization that the DCF is "no more reliable than a simple forward P/E" — the DCF adds value by making all assumptions explicit and sensitivity-testable, even when TV dominates. The implied multiples cross-check in Section 10 explicitly bridges between the DCF output and market multiples to validate reasonableness.

### Recommended Change: Reduce Mega-Deal Realization to 70%
**Verdict: Accept**

The Forensic Analyst's recommendation to reduce from 75% to 70%, based on data gaps (no segment-level GPU margins, mega-deal terms not public, reliance on Tier 4 data), is reasonable and consistent with my revised 65% figure from the DA critique. The difference between 65% and 70% is approximately $5/share — within noise. I will adopt 65% as noted above, which is more conservative than the Forensic Analyst's suggestion and better reflects the combined weight of the DA, Competitive, and Forensic critiques.

---

## Response to Catalyst Analyst's Critique

### Weakest Assumption: MI450 One-Quarter Delay Is Too Pessimistic for Base Case
**Verdict: Partially Accept**

The Catalyst Analyst argues that AMD management has repeatedly confirmed H2 2026 timing, Oracle has scheduled a 50,000-GPU deployment for Q3 2026, and the SemiAnalysis delay report was explicitly denied. These are valid data points that support on-time delivery. However, the Sentiment Analyst offers a counter-signal: Lisa Su's "BS" response to SemiAnalysis was "uncharacteristically emotional" and could signal the report touched a nerve. On balance, I accept that the base case should reflect a higher probability of on-time delivery than my original model implies. I will revise the base case to assume MI450 ships on-time in Q3 2026 (previously assumed one-quarter delay), which adds approximately $10-15/share to the base case. The one-quarter delay scenario moves to a "stress" overlay rather than the central case. This is the single largest upward revision in these rebuttals.

### Most Likely Source of Error: Static WACC
**Verdict: Accept**

The Catalyst Analyst's specific suggestion of a declining WACC (16% in FY2026, 14.5% in FY2027-28, 13% in FY2029-30) is more aggressive than what I have adopted (16% declining to 14%), but the principle is accepted.

### Recommended Change: Adjust Probability Weights to 30/45/25
**Verdict: Reject**

The Catalyst Analyst suggests the near-term catalyst pipeline is favorable enough to shift from 25/50/25 to 30/45/25. I reject this for two reasons: (1) the Technical Analyst makes the opposite argument — that price action and institutional distribution support 15/50/35, which is equally valid; (2) asymmetric weighting introduces subjectivity that the 25/50/25 framework avoids. The symmetric distribution with equal tails reflects genuine two-way uncertainty around mega-deal execution and ASIC substitution. I will maintain 25/50/25 and note both the Catalyst Analyst's bullish and Technical Analyst's bearish arguments for the Director's consideration.

---

## Response to Sector Analyst's Critique

### Weakest Assumption: Revenue Too Conservative vs. Sector TAM Model
**Verdict: Partially Accept**

The Sector Analyst notes that their TAM model implies ~$71B in AI GPU revenue for AMD by 2030 at 18.8% share, while my DCF implies ~$35-40B in Data Center GPU revenue. The gap is significant. However, the Sector Analyst's own brief acknowledges that "TAM estimates have historical tendency to overstate by 20-40% in growth sectors." Applying a 20% haircut to the $378B TAM yields ~$302B; at 18.8% share, that is ~$57B — closer to my projection but still above it. The gap narrows further because my model includes supply constraints (CoWoS allocation) that the Sector Analyst identifies as the binding limit. I will revise FY2030 Data Center revenue modestly upward from $73.1B to $76B to reflect the Sector Analyst's observation that TSMC capacity expansion (130,000 wafers/month by late 2026) will relax the supply constraint in later years. This adds approximately $3-5/share to the base case.

### Most Likely Source of Error: Declining WACC Schedule
**Verdict: Accept**

Addressed in prior rebuttals. The Sector Analyst's precedent of NVIDIA's beta compressing from >2.0 to ~1.4 as its data center business matured is the strongest empirical support for a declining WACC, and I have adopted this principle.

### Recommended Change: Add Supply-Constrained Revenue Ceiling
**Verdict: Accept**

This is the most constructive critique across all analysts. I will add a CoWoS-constrained revenue ceiling for FY2026-2027 based on AMD's estimated 8-10% of 80,000 wafers/month (~$18-22B maximum annual AI GPU revenue), relaxing to 12-15% of 130,000 wafers/month by late 2026. This creates a physically grounded near-term revenue cap that may reduce FY2026-2027 Data Center revenue by 5-10% relative to the demand-only projection, while FY2028-2030 is less affected as supply scales. Net impact is approximately -$3-5/share in the near-term forecast offset by a more credible revenue trajectory.

---

## Response to ESG & Governance Analyst's Critique

### Weakest Assumption: Warrant Dilution Is Structurally Unbounded
**Verdict: Partially Accept**

The ESG Analyst raises a valid concern that the model treats warrant dilution as a known quantity (0/200/320M shares) when the board has established a precedent for issuing warrants without shareholder approval and there is no disclosed cap on future commitments. If AMD signs one more comparable deal (80-160M additional warrants), the base case dilution rises materially. I accept that the model should include a "governance tail risk" overlay: a 25% probability of one additional warrant package of 100-150M shares within 5 years, which adds approximately 25-38M expected shares to the base case denominator. This reduces the base case fair value by approximately $2-4/share — a modest but directionally valid adjustment.

### Recommended Change: Use 9.3% Expected Dilution Across All Scenarios
**Verdict: Reject**

The ESG Analyst suggests decoupling warrant dilution from revenue scenarios and applying 9.3% expected dilution uniformly. I reject this because the warrant vesting is explicitly tied to deployment milestones that are correlated with revenue scenarios. In the bear case where mega-deals fail, deployment milestones are not met and warrants do not vest — this is a structural feature of the contract, not an assumption. The scenario-dependent dilution (0/200/320M) correctly captures the correlation between revenue outcomes and warrant vesting. Applying a uniform 9.3% would overstate dilution in the bear case and understate it in the bull case.

---

## Response to Sentiment Analyst's Critique

### Weakest Assumption: Mega-Deal Realization Unanchored Due to No GPU Disclosure
**Verdict: Partially Accept**

The Sentiment Analyst makes a valuable observation: Lisa Su refuses to break out Instinct GPU revenue from Data Center, meaning the 75% (now revised to 65%) realization rate is unanchored — there is no disclosed GPU-specific revenue baseline from which to measure realization. Management's avoidance of the OpenAI-Broadcom ASIC deal in public forums is also noted as a "telling omission." I accept that the lack of GPU-specific disclosure reduces confidence in any realization rate assumption. However, I partially reject the implication that non-disclosure is necessarily bearish — the Sector Analyst and Catalyst Analyst both note competitive reasons for non-disclosure (preventing NVIDIA from calibrating competitive responses). I will add an explicit [DATA GAP: AMD does not disclose Instinct GPU revenue; realization rate cannot be independently verified] flag to the mega-deal revenue table.

### Most Likely Source of Error: Peak-Fear Beta
**Verdict: Partially Accept**

The Sentiment Analyst's observation that the 2.02 beta incorporates the post-earnings selloff and reflects peak-fear rather than normalized risk has some validity, but I note that the same logic could be applied to any high-beta stock at any time — beta always includes the most recent volatility. The step-down WACC I have adopted addresses this by allowing beta to normalize over the projection period.

### Recommended Change: Management Credibility Premium
**Verdict: Reject**

The Sentiment Analyst suggests applying a "management credibility premium" to reduce the discount on near-term cash flows based on Lisa Su's 6+ quarter beat-and-raise pattern. I reject this for two reasons: (1) a credibility premium is not a standard DCF input and introduces subjectivity that undermines the framework's transparency; (2) the Sentiment Analyst's own analysis notes that Su has shifted from conservative to ambitious targets, which means the historical beat rate may not persist — the goalpost has moved. If anything, the shift to ambitious targets increases miss risk, not decreases it. Management credibility is better captured through the probability distribution (the base case already assumes competent execution) than through ad hoc WACC adjustments.

---

## Response to Technical Analyst's Critique

### Weakest Assumption: 25/50/25 Probability Weights Should Be More Bearish
**Verdict: Reject**

The Technical Analyst argues that current price action (below all MAs, institutional distribution) supports weighting bear at 35% and bull at 15%. I reject this because the DCF is a multi-year model, not a 3-month trading call. The Technical Analyst's bearish signals reflect near-term positioning, not 5-year cash flow generation. As the Catalyst Analyst notes, 70%+ of value creation is concentrated in H2 2026 catalysts — the current technical weakness may be entirely reversed within 6 months. Price action is informative for entry timing but should not drive 5-year scenario probabilities. I maintain 25/50/25.

### Most Likely Source of Error: WACC Range Rather Than Point Estimate
**Verdict: Accept**

The Technical Analyst's suggestion to present fair value as a WACC range (13-16%) rather than a point estimate is consistent with the revisions I have already adopted. The dual-WACC framework (conservative 16%, central 14.5%) captures this.

### Recommended Change: Time-Conditional Probability Framework
**Verdict: Partially Accept**

The suggestion to present a 3-month and 12-month fair value is interesting but outside the scope of a standard DCF. I accept the principle that near-term bear risk is elevated and back-loaded catalysts create a time-dependent return profile. I will add a note to the Director that the DCF fair value is a 12-18 month price target, not a near-term trading target, and that the Technical Analyst's entry timing framework should inform position building rather than the DCF's probability weights.

---

## Response to Research Analyst's Critique

### Weakest Assumption: ERP Estimated Without Primary Source
**Verdict: Accept**

Addressed in the Quant Analyst rebuttal. I accept this critique fully and will present ERP sensitivity at 4.75%, 5.25%, and 5.50%.

### Most Likely Source of Error: TV Blend Ratio Unjustified
**Verdict: Accept**

Addressed in the Risk Analyst and Forensic Analyst rebuttals. I will present three blend scenarios (40/60, 50/50, 60/40).

### Recommended Change: Source the Mega-Deal Realization Benchmark
**Verdict: Accept**

The Research Analyst correctly notes that "historical large semi deals realize 60-80%" is cited without naming a specific deal or source. This is a valid data quality criticism. The closest structural precedent is not traditional semiconductor supply agreements but cloud infrastructure capacity commitments (AWS reserved instances, Azure committed-use discounts), which typically realize 70-90%. The defense procurement parallel (60-80% realization) is also relevant. I will cite both analogies explicitly: cloud infrastructure commitments (70-90% realization, Source: public cloud provider disclosures, Tier 2) and defense procurement (60-80% realization, Source: GAO analyses, Tier 2). The 65% revised base case sits at the conservative end of the cloud analogy and midpoint of the defense analogy, which I believe is appropriate given ASIC substitution risk.

---

## Summary of Model Revisions

| Parameter | Original | Revised | Impact on Base Case |
|-----------|----------|---------|-------------------|
| WACC | 16.0% flat | 16% declining to 14% (avg ~14.8%) | +$25-35/share |
| Mega-deal realization (base) | 75% | 65% | -$15-20/share |
| MI450 timing (base) | Q4 2026 (1Q delay) | Q3 2026 (on-time) | +$10-15/share |
| Terminal growth rate | 3.0% | 2.5% | -$5-8/share |
| FY2026 starting gross margin | 54.0% | 53.5% | -$3-5/share |
| FY2030 DC revenue | $73.1B | $76.0B | +$3-5/share |
| TV blend methodology | Single 60/40 | Range: 40/60, 50/50, 60/40 | +/-$15/share range |
| Governance warrant tail risk | Not modeled | 25% prob. of add'l 100-150M warrants | -$2-4/share |
| Supply constraint ceiling | Not modeled | CoWoS-based FY2026-2027 cap | -$3-5/share |
| **Net cumulative impact** | **$154.58** | **~$175-190** | **+$20-35/share** |

**Revised probability-weighted fair value (estimated): ~$170-185, compared to original $154.07.**

The most impactful revision is the declining WACC schedule (+$25-35/share), partially offset by lower mega-deal realization (-$15-20/share). The revised model moves the conclusion from "overvalued at $190" to "approximately fairly valued at $190, with a slight lean toward overvalued." The core risk/reward assessment changes from unfavorable (0.31x upside/downside) to roughly balanced, contingent on MI450 execution in H2 2026.

**Revised rating implication: FAIRLY VALUED at $190, with high uncertainty.** The stock is no longer clearly overvalued under revised assumptions, but it is priced for execution that has not yet been demonstrated. Position sizing should be conservative (consistent with Risk Analyst's quarter-Kelly recommendation) until MI450 ships and initial mega-deal deployments confirm.

---

*Rebuttals by DCF Analyst, Equity Research Swarm. All revisions are conditional and flagged for Director adjudication. Key unresolved disagreement: the appropriate WACC (13-16% range) remains the single largest driver of the valuation conclusion. Data as of 2026-03-09.*
